DNA plasmid HIV vaccine design, number of doses, participant gender, and body mass index affect T-cell responses across HIV vaccine clinical trials

Por Morgan, C, Jin, X, Yu, X, De Rosa, S, Kublin, J, Metch, B, Keefer, M, NIAID, H
Publicado em 2012